Cargando…
Establishing a Multidisciplinary Framework to Study Drug‐Drug Interactions of Hormonal Contraceptives: An Invitation to Collaborate
Hormonal contraceptive agents (HCAs) are widely used throughout the world, and women taking HCAs are likely to take other medications. However, little is known about the clinical effect of most drug‐drug interactions (DDIs) associated with HCAs. A team of interdisciplinary outcomes and pharmacometri...
Autores principales: | Lesko, Lawrence J., Vozmediano, Valvanera, Brown, Joshua D., Winterstein, Almut, Zhao, Ping, Lippert, Jörg, Höchel, Joachim, Chaturvedula, Ayyappa, White, Annesha, Schmidt, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263668/ https://www.ncbi.nlm.nih.gov/pubmed/30260082 http://dx.doi.org/10.1002/psp4.12357 |
Ejemplares similares
-
Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development
por: Srinivasan, Meenakshi, et al.
Publicado: (2020) -
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug‐Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
por: Cicali, Brian, et al.
Publicado: (2020) -
Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
por: Schmidt, Stephan, et al.
Publicado: (2019) -
A Pharmacoepidemiologic Approach to Evaluate Real-world Effectiveness of Hormonal Contraceptives in the Presence of Drug–drug Interactions
por: Sarayani, Amir, et al.
Publicado: (2020) -
Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
por: Brown, Joshua D., et al.
Publicado: (2019)